The mode of failure of contemporary implantable vascular stents varies according to the final expanded diameter. Large diameter devices, such as aortic stent grafts, are most susceptible to corrosion that leads to degradation of mechanical integrity. Small-diameter and medium-diameter stents, such as coronary and renal stents, respectively, are prone to neointimal hyperplasia that leads to in stent restenosis. Because of the large number of coronary stent procedures performed each year, 1 in stent restenosis is by far the most important limitation of these devices.
The patency of a stent depends on: 1, the clinical profile of the host; 2, the characteristics of the target lesion; 3, procedural factors; and 4, technical features of the stent, including its design and material composition. Because the engineering aspects of a stent can hopefully be controlled and optimized, this review focuses on the analysis of current data and work in progress in the area of stent design and material composition.
Restenosis is the loss of the luminal diameter gain obtained at the time of initial stent placement from neointimal hyperplasia. The timing of its occurrence is similar to other percutaneous coronary interventions. In stent restenosis typically develops 1 to 3 months after stent placement 2,3 but may be progressive up to 18 months. 4 The late loss of the stent lumen from intimal hyperplasia was found to be a constant proportion of the initial luminal gain. Because stents produce the largest initial gain, compared with balloon angioplasty and atherectomy, they have the largest late loss. 5 This finding is consistent with the fact that a large increase in the lumen generally involves a high degree of vessel wall damage, in turn producing a proportionally large intimal hyperplastic response. The correlation of the degree of stent-induced injury to the vessel wall, with the extent of intimal hyperplasia, has been shown in experimental models. 6 Schwartz et al 6 showed a close correlation between the degree of penetration of the stent struts into the layers of the vessel wall and intimal proliferation measured as cross-sectional area. In human specimens obtained at autopsy or after surgery, Farb et al 7 confirmed a relationship between injury and extent of intimal formation.
More recently, the degree of intimal hyperplasia has been correlated with histologic evidence of inflammation in the stented vessel. Acute inflammatory infiltrates of neutrophils are prevalent a few days after stent placement, 7 and macrophages and lymphocytes predominate 6 months after stenting and later. 8 However, granuloma formation has been observed in the vicinity of the stent struts in stented vessels with intimal hyperplasia, independent from the degree of injury. 9 Although inflammatory infiltrate has been identified predominantly in stented vessels with medial disruption and penetration of stent struts in the lipid core, 8 some investigators have called attention to the role of particulate contaminants of stents producing inflammation. Whelan, van Beusekom, and van der Giessen 10 identified starch and fibers in tissues surrounding implanted stents, and Bayes-Genis et al 11 showed that pressure rinsing of 13 An elevated fibrinogen level is likely to increase the risk for stent restenosis because it has been associated with increased failure rate of vascular implants, as in lower extremity bypass procedures.
14 Lesion characteristics, such as small diameter vessel, long lesions, ostial lesions, complex lesions, complete occlusions, high-grade stenoses, and previously stenotic lesions, are all associated with an increased risk of restenosis. Finally, procedural variables, such as placement of multiple stents and stent type, have a strong influence on the procedural outcome. 12 Among all of the currently known risk factors, the technical aspects of the stent are the most amenable to change. Optimization of stent design and materials hopefully will lead to improved clinical results.
STENT DESIGN AND CLINICAL EXPERIENCE
Kastrati et al 15 examined the clinical outcome in patients treated with five different designs of stainless steel coronary stents and found significant differences in the event-free survival rates at 1 year. Despite the many variations involved in the design of stents, their configuration can be generally classified into slotted and coiled. Slotted stents have the members disposed predominantly along the longitudinal axis and are inherently rigid along this axis. Coiled stents have the members disposed substantially perpendicular to the long axis and are therefore more flexible. The introduction of perpendicular members into the design of stents to attain longitudinal flexibility results in advantages inherent to ease of manipulation and enhanced technical success. However, coiled stents seem to have a lower patency rates in the long term. The coiled GRII stent (Cook Inc, Bloomington, Ind) and the Wiktor stent (Medtronic, Minneapolis, Minn) were compared with the slotted Palmaz-Schatz stent (Cordis, J&J, Warren, NJ) in patients with coronary artery disease and both were found to have higher restenosis rates. 16 A randomized study that compared the GRII stent with the Palmaz-Schatz stent also showed a higher restenosis rate for the former. 17 Escaned et al 18 found that the restenosis rate in coiled stents was double that in slotted stents. However, the differences between slotted and coil stents have recently become blurred because many current stents combine features of slotted design, such as longitudinal members with transverse elements to provide flexibility.
The plethora of balloon expandable stent designs in clinical use today evolved from the original Palmaz and Palmaz-Schatz slotted balloon expandable stents. The basic function of the balloon expandable stent relies on a fundamental functional unit consisting of expanding rings joined together in a variety of different ways. The mechanism of action of the balloon expandable rings depends on plastic deformation of the angle at which the struts connect, imposed by the radial force of a balloon. In the traditional slotted stent, these ring units are joined at the angles, forming spaces or cells. Staggered cells constitute the mesh. Overall, separating the rings apart and joining them at alternate points or with various flexible connectors allows the stent to attain longitudinal flexibility.
SURFACE TOPOGRAPHY AND STENT ENDOTHELIALIZATION
Several factors influence the rate of coverage of a metal surface with endothelium spreading from a proximal source on a flat featureless surface. The rate of endothelial cell (EC) coverage is influenced more by migration than by proliferation. 19 An important factor that affects the rate of endothelialization is flow shear rate. In our laboratory, we found that in static culture conditions, the rate of EC migration on a metal surface such as stainless steel or nitinol is initially 10 m/h and increases to 15 m/h 10 days later. In the presence of flow at normal shear rates, the migration Bars indicate mean number of ECs per mm 2 on stainless steel microfabricated surfaces, with square section grooves from 7 to 20 m wide. Grooves of defined width were created with photolithographic process. Grooved stainless steel 1 ϫ 1-cm coupons were implanted on endothelialized gel surface as described previously, and cells were allowed to migrate onto surface for 7 days with static culture conditions. Control indicates flat surface. Surface with 15-m grooves has significantly larger cell population.
rate increases to 25 m/h by 7 days. 19 With normal shear, ECs migrate in the direction of flow with little migration observed against flow. With low shear, migration is slower and tends to occur in every direction (Fig 1) . This observation agrees with the fact that coronary stents placed with minimal injury to the endothelium may require only a few days to endothelialize. In contrast, in stents placed in totally occluded vessels or after large endothelial injury, such as after catheter endarterectomy or laser revascularization, endothelializaton time may be prolonged from several weeks to a few months.
In addition to flow shear, the topography of the surface plays a role in EC coverage. An obstacle raised above the plane of the vessel's inner surface, such as an intravascular stent, hinders cell progression in a manner proportional to its height. Because stents have complex geometries, an experimental model of a stent was made with simple shapes of flat material with a thickness commensurate with the thickness of vascular stents. Pieces of progressively increasing heights from 25 to 250 m were placed on a monolayer of ECs in a laminar flow chamber at physiologic wall shear stress (15 dynes/cm 2 ). The number of cells able to gain access on top of the obstacles decreased significantly with heights of 100 m and greater, compared with 25 m. No cells were found on top of 250 m-thick obstacles 20 ( Fig  2) . These experimental results agree with clinical experience with intravascular stents having increased failure rates with increasing wall thickness. Kastrati et al 21 studied two coronary stents of identical design and wall thicknesses of 50 and 140 m and encountered significantly higher clinical and angiographic restenosis rates with the later. This reflects impaired endothelialization and increased intimal formation with the larger obstacles caused by thicker stent struts.
With slow motion video recordings of ECs migrating on a flat surface under flow, we observed that cells migrate downstream not in straight lines but rather in a zigzag pattern. This motion increases the probability of encounter with other migrating cells. Cell collisions reduce migration speed by contact inhibition. Multiple collisions halt migration and allow confluence. If a migrating cell encounters a linear feature on the surface, such as a scratch disposed at an angle to the direction of flow, it follows the feature (Fig 3) . If multiple parallel scratches are made on the surface, the cells migrate in straight lines along the scratches (Fig 4) . The migration speed is thus increased because the side to side movement is inhibited. 22 The increase in migration speed reflected on the cell count on the leading edge of the material is dependent on the width of the grooves, as it relates to cell size (Fig 5) . Narrow grooves prevent cell progression, and excessively large grooves allow the cells to wander, therefore slowing down migration speed. With stents with microscopic parallel grooves created on the inner surface, we found significantly accelerated endothelialization rates in carotid artery stents of pigs 1 week after placement. 23 With the hypothetic assumption that no endothelial damage is produced by the stent placement, ECs adjacent to the raised stent struts slough because of superficial microflow disturbances. This is shown experimentally by measuring the area devoid of ECs shortly after placement of geometric obstacles on an EC monolayer. The angle of the sides of the object relative to the flow direction influences the extent of endothelial slough. The lowest EC loss is observed adjacent to the edges along the flow, and the largest on the down flow side of edges disposed transversely. Intermediate degrees of EC loss were found on the transverse upstream edge and on the 45-degree edge. 20 This finding supports the clinical experience of higher restenosis rates for coiled stents with struts substantially perpendicular to the direction of flow. 18 The influence of the edge angle of stent struts in the vertical axis (radial direction in a vessel lumen) also was evaluated. Shallow angles in objects disposed perpendicular to flow allowed the largest number of cells to migrate on top of the obstacle. 24 This observation indicates that stent struts should have blunted edges or, even better, a trapezoidal cross section.
The density of the stent mesh has an influence on the intimal hyperplastic response. Stents with few struts spaced far apart produce more intimal hyperplasia than more struts around the circumference if they are evenly distributed. This is related to wall indentation with a few stent struts producing a polygonal rather than a circumferential lumen. 25 However, increased strut density may come at the price of larger metal surface, and this in turn may affect patency. Of course, the many variables influenced by stent design, such as total metal surface, radiopacity, radial strength, expandability ratio, shortening, and flexibility, affect each other. Typically, compromises must be reached to attain the best possible results within technical limitations.
STENT MATERIAL COMPOSITION
Design advances outpace material developments in all vascular prosthetic developments from stents to artificial hearts. 26 Unlike design features, the impact of the material composition on the clinical performance of stents is difficult to ascertain. Slow release of metal ions in the tissues surrounding metal implants may be the reason for local inflammatory and hyperplastic responses observed with stents. Corrosion products from alloys commonly used in the fabrication of stents, such as stainless steel 316L and nitinol, exhibit biotoxicity. 27, 28 Nitinol has shown to have a local inflammatory effect by causing increased monocyte secretion of interleukin-1 ␤.
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Cobalt, nickel, and chromium are all capable of inducing a cutaneous hypersensitivity reaction. [30] [31] [32] Interestingly, Koster et al 33 found a correlation between coronary steel stent restenosis and contact dermatitis to nickel and molybdenum. Kastrati et al 34 and vom Dahl et al 35 found increased angiographic and clinical restenosis rates in goldcoated stents compared with identical steel counterparts. In our laboratory, time of flight secondary ion mass spectroscopic images of gold-coated stents showed evidence of defects in the top gold layer, which may explain the poor outcome (Fig 6) . However, Edelman et al 36 observed a decrease in intimal hyperplasia and inflammation if goldelectroplated steel stents were further treated with a baking process. Reportedly, the thermal treatment seals the defects of the plated gold layer and prevents the untoward tissue response.
The presence of defects in a material coating another material, both with different electric charges, may create conditions for localized galvanic currents leading to corrosion and biologic interactions different from adjacent areas. Gold's separate position in the electromotive force series from chromium and titanium explains such an occurrence. 37 We have documented with imaging a marked variability in the surface electric charge of steel sputter coated with gold and palladium with atomic force microscopy force volume arrays. 38 This provides objective evidence of electric heterogeneity produced by the incomplete coat (Fig 7) . The surface oxide layer may be defective (Fig  8) or develop defects as a result of deformation of the stent. If this happens, the bulk stent material is exposed and a corrosion reaction may occur.
Several papers report advantages of nitinol 39, 40 versus stainless steel in regards to decreased thrombogenicity. However, we could not confirm such results in our laboratory. In ongoing work, we found stainless steel to have the lowest thrombogenicity among other metals and alloys commonly used for the manufacture of stents. However, the coating of stents with nonmetallic materials has been tried extensively in the pursuit to avoid real or perceived limitations of metals as vascular implants. Unfortunately, much of the experimental and clinical work on new coating materials does not directly compare the modified stents with bare metal controls. Coatings in general have potential disadvantages relating to cracks and discontinuities, fluid seepage, and delamination. Aside from the problems in stability of the coating process, Van der Giessen et al 41 found that covering steel stents with polymeric materials resulted in marked inflammation with most polymers tested. Coating metal stents with phosphoryl choline apparently adds no significant advantage. 42 Ceramic-like coating, such as diamond-like films, was found to have no significant advantages over bare metal stents. 43 Silicon carbide 44 and turbostratic carbon 45 seem to be adequate surface materials, but superiority over metal stents was not proven. In comparison of stainless steel with frequently used polymers and ceramic materials, we found that, except for polyhydroxyethylmethacrylate, steel has the lowest thrombogenic potential.
With the limitations of the current technology, the widespread clinical use of stainless steel in stent manufacture for the past 10 years seems to confirm the adequacy of this material and its place as state-of-the-art material. Reported clinical series of steel stents with 9 years of follow-up attest to the durability of the device and give important reassurance about sustained long-term benefit. 46, 47 
Fig 9.
Pie chart of surface atomic mass composition with radiograph photoelectron spectroscopic analysis of fracture surface of medical-grade steel tubing in three stages of cold drawing. Top graph corresponds to 10 mm-diameter tube; middle and bottom graphs represent 6 mm-diameter and 2 mm-diameter tubes. As diameter decreases, iron decreases markedly as sulfur and silicone increase.
CONTAMINANTS ON APPROVED STENTS
With surface-sensitive analysis, we found a significant amount of unexpected chemicals on the surface of stents approved for clinical use in the United States. The most abundant material found was the lubricant polydimethylsiloxane. 48 Polydimethylsiloxane is used in the extrusion of plastic catheters and is omnipresent on the surface of delivery and balloon catheters. The material is transferred on contact with the stent because of its large spreading capability. However, polydimethylsiloxane appears biologically inert in vessels and does not seem to pose a disadvantage. Stent manufacturers try to clean stents from polydimethylsiloxane and other contaminants remaining after processing, and the result of this attempt may be additional deposition of chemicals on the surface of the stent, such as sodium. The sodium contamination was found with x-ray photoelectron spectroscopy to be in the form of hydroxide rather than any salt, pointing to the use of NaOH-containing cleaning agents.
The bulk material of stents also has significant contaminants, resulting from the industrial processing of the wrought material in tubing, sheets, or wire form. For example, multiple cold drawings and annealing of the tubing material used for stent manufacture leave increasing levels of residues from high pressure lubricants in the grain boundaries (Fig 9) .
Electropolishing of steel eliminates much of these contaminants, leaving resilient chromium oxide as the predominant surface constituent. This may be the reason for the improved healing response of vessels to electropolished compared with nonpolished stents. 49 However, surface imaging of current stents, approved and ready for patient implant, still shows significant impurities (Fig 10) . The result of this is chemical heterogeneity of the stent surface. Chemical imaging of the surface reveals large heterogeneity in the distribution of the main components of steel, such as chromium and iron, and materials that are different from the nominal composition. Because protein interaction with metal surfaces depends on the physical and chemical properties of such surface, variability of the surface may result in heterogeneous protein distribution. This in turn may result in uneven cellular attachment and healing. It is therefore possible that the lack of material surface uniformity in current stents may account for unpredictable healing patterns and procedural outcome.
Uneven bulk composition may also be responsible for mechanical failure in large stent devices. Decreased nickel concentration was observed at areas of structural failure from corrosion in nitinol aortic stent grafts. 50, 51 Structural failure of large stents, subjected to much larger strain compared with small and medium stents, may be related to focal heterogeneities and material inclusions leading to galvanic corrosion and eventual fracture.
Because material contamination and heterogeneities seem to be suspect for inadequate healing patterns and material failure, it appears reasonable to emphasize the need for improved materials, with homogenous composition at the molecular level and freedom from extraneous chemicals on the surface and in the bulk. The use of drug-eluding coatings is effective and seems reasonably safe, 52 but uncertainty about long-term results and cost considerations make this approach debatable. Despite the current paucity of information on the basic mechanisms of interaction of the vessel wall with stents, new developments should be aimed at improving currently used materials rather than suppressing biologic responses that are not completely understood. 
